Drawing for BY PATIENTS, FOR PATIENTS

USPTO serial 88091973

BY PATIENTS, FOR PATIENTS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
DANTZLER, LAUREN ALEXANDRIA
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with BY PATIENTS, FOR PATIENTS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

KERRIJANE JOHN

KERRIJANE JOHN FISH & RICHARDSON PCPO BOX 1022MINNEAPOLIS, MN 55440-1022UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals, medical and veterinary preparations for genetically based diseases and rare disorders; sanitary preparations for medical purposes; dietetic food and substances, in the nature of sugar adapted for medical or veterinary use, food for babies; dietary supplements for humans and animals; medical plasters; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; medicines for human purposes for the treatment of genetically based diseases and rare disorders; pharmaceuticals for genetically based diseases and rare disorders; pharmaceutical preparations for use in the treatment of genetically based diseases and rare disorders; pharmaceutical preparations for gene therapy and cell therapyABANDONED—
042design and development of computer hardware and software; research and development of orphan drugsABANDONED—
044Medical services; veterinary services; hygienic and beauty care for human beings or animals; horticulture services; agricultural services, namely, compost spreading; forestry services, namely, insecticide spraying for forestry; health and medical counselling; providing health care and medical information; providing a website featuring educational information regarding rare diseases, orphan drugs, gene therapy, cell therapy and other treatment options; Personal and social services rendered by others to meet the needs of individuals, namely, providing patient advisory and information services regarding the coordination and combination of efforts by patients and families in driving scientific and medical research and development; Health care advisory and information services for patients and their families regarding the coordination of medical services; Advice and consultation services, namely, providing advice, information and assistance to patients and their families in dealing with medical service providers, hospitals, insurance companies, and others involved in patient careABANDONED—
045Personal and social services rendered by others to meet the needs of individuals, namely, providing patient advocacy services regarding the coordination and combination of efforts by patients and families in driving scientific and medical research and development; providing patient advocacy services in the field of gene therapy and cell therapy; providing case management services, namely, coordinating patient and family health care medical services; health care advocacy services for patients and their families regarding the coordination of medical services; health care case management advice and consultation services, namely, medical care coordination for patients and familiesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 27, 2020ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Aug 27, 2020OP.TOPPOSITION TERMINATED NO. 999999—
Aug 27, 2020OP.DOPPOSITION DISMISSED NO. 999999—
Apr 8, 2020OP.IOPPOSITION INSTITUTED NO. 999999—
Jan 9, 2020ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Dec 10, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 10, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 20, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 5, 2019ALIEASSIGNED TO LIE—
Oct 29, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 23, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 23, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 23, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Oct 21, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 21, 2019COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 18, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 18, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 25, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 25, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Jun 25, 2019CNSLSUSPENSION LETTER WRITTEN—
Jun 12, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 11, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 11, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 12, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 12, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 12, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2018DOCKASSIGNED TO EXAMINER—
Sep 4, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 28, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance